antibodies
Advertisement
Suphamai Bunnapradist discussed the phase 3 TRANSCEND study of felzartamab to treat late AMR after kidney transplantation.
According to a poster at the 2022 American Society of Clinical Oncology, the combination of the anti-CD47 monoclonal ...
The findings of a new study suggest that previous antibody responses to harmless coronaviruses augments immunity to ...
Individuals at highest risk for adverse outcomes of SARS-CoV-2 infection include the elderly and those with pre-existing ...
On Thursday, May 27, 2021, here are the latest COVID-19 numbers around the world, according to statistics aggregator, ...
A study published in The Lancet Haematology reviewed responses to the first dose of the SARS-CoV-2 vaccine in patients ...
Cancer patients infected with SARS-CoV-2 (COVID-19) produce antibodies at a similar rate to non-cancer patients, ...
Up to almost half of patients who develop blood clots from a COVID-19 get them from a particular autoimmune antibody ...
DocWire News interviews Dr. Joshua Sabari, of the Perlmutter Cancer Center at NYU Langone Health, about recent results ...
A research team at Katholieke Universiteit Leuven in Belgium has recently created a DNA injection that can induce the ...
The U.S. Food and Drug Administration (FDA) approved ID CORE XT, a molecular-based assay that can be used to ...
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.